Close Menu

digital microfluidics

The company is currently looking for beta customers to test the system for whole-genome sequencing, exome sequencing, and RNA-seq library prep workflows.

The collaboration will combine Twist's target enrichment and sample library preparation kits and Miroculus' Miro Canvas microfluidics system.

Formerly known as SlipChip Corp, the firm has recently won nearly $10 million in funding to hone its approaches to sepsis and CT/NG testing.

The firm aims to commercialize its platform for infectious disease testing in the US by mid to late 2019, and continues to explore additional financing options.

NEW YORK (GenomeWeb) ― Manipulating miniature droplets and subjecting them to high temperatures on an open digital microfluidic device leads to evaporation that can seriously disrupt concentration-dependent enzymatic reactions, like PCR.

NEW YORK (GenomeWeb) — Headed by a co-founder of Advanced Liquid Logic, startup company Baebies has entered the second stage of Small Business Innovation Research funding from the National Institutes of Health to develop a point-of-care cytomegalovirus assay appropriate for routine screening of n

Scientists and engineers at Sandia National Laboratories have built a prototype of a modular microfluidic library preparation platform that will allow users to process small numbers of DNA samples for next-gen sequencing in an automated fashion.

Following Illumina's acquisition of digital microfluidics firm Advanced Liquid Logic last month, the company is now planning how it will integrate ALL's electrowetting technology into new sequencing sample preparation products and evaluating what other applications to pursue that

NEW YORK (GenomeWeb News) – Illumina's second quarter revenues rose 23 percent year over year, the company announced after the close of the market on Tuesday.
Separately, it also announced it has acquired liquid handling solutions firm Advanced Liquid Logic for up to $96 million.

GenMark is anticipating that the launch of its new, sample-to-answer multiplex testing instrument later this year will allow it to pursue a greater share of the global molecular diagnostics market by targeting labs without the sample preparation capabilities necessary to use its

Pages

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

Time magazine looks into how liquid biopsies are changing cancer care.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.